| 51 |
16195625 | Valsartan decreases type I collagen synthesis in patients with hypertrophic cardiomyopathy. | 2005 Oct |
1 |
| 52 |
14973301 | Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan. | 2004 Mar |
1 |
| 53 |
15005273 | Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. | 2004 Feb |
1 |
| 54 |
15071355 | Effects of valsartan and valeryl 4-hydroxy valsartan on human platelets: a possible additional mechanism for clinical benefits. | 2004 May |
2 |
| 55 |
15485399 | The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes. | 2004 Nov |
1 |
| 56 |
12515751 | Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation. | 2003 Jan 7 |
1 |
| 57 |
12846741 | STAT proteins mediate angiotensin II-induced production of TIMP-1 in human proximal tubular epithelial cells. | 2003 Aug |
2 |
| 58 |
14620933 | Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy. | 2003 Sep |
1 |
| 59 |
14643571 | Expression of endothelial angiotensin II receptor mRNA in pregnancy-induced hypertension. | 2003 Dec |
1 |
| 60 |
14871033 | Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine. | 2003 Dec |
1 |
| 61 |
11963637 | [Efficacy-safety relationship of AT1 angiotensin II receptor antagonists: current data]. | 2002 Jan-Feb |
1 |
| 62 |
12409989 | Pharmacokinetics of multiple doses of valsartan in patients with heart failure. | 2002 Nov |
1 |
| 63 |
11467764 | Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation. | 2001 |
1 |
| 64 |
11561228 | Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects. | 2001 Sep |
1 |
| 65 |
11683476 | Pharmacology of AT1-receptor blockers. | 2001 |
1 |
| 66 |
11103753 | Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers. | 2000 Nov |
1 |
| 67 |
11131281 | Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells. | 2000 Nov |
1 |
| 68 |
11206708 | Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors. | 2000 Nov-Dec |
8 |
| 69 |
12555316 | [Tolerance to valsartan in office practice in 3,197 hypertensive patients (the VALSE study)]. | 2000 Feb |
1 |
| 70 |
9761285 | Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists. | 1998 Oct |
1 |
| 71 |
9342579 | Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects. | 1997 |
1 |
| 72 |
9342580 | Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol. | 1997 |
1 |
| 73 |
7867676 | Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects. | 1994 |
1 |
| 74 |
7980530 | Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor. | 1994 Oct 28 |
1 |